Self-Management Program for Depression and High Blood Pressure Risk
(TEAM-Red Trial)
Trial Summary
What is the purpose of this trial?
The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using antihypertensive medications (medications for high blood pressure).
What data supports the effectiveness of the treatment TEAM-Red for managing depression and high blood pressure risk?
Research shows that integrating depression treatment into hypertension care can improve both blood pressure control and depressive symptoms. Additionally, self-management programs and interventions that consider social factors have been effective in improving health outcomes for patients with both conditions.12345
Is the Self-Management Program for Depression and High Blood Pressure Risk safe for humans?
How is the TEAM-Red treatment different from other treatments for depression and high blood pressure?
TEAM-Red is unique because it integrates depression treatment into hypertension care, using a team-based approach involving Licensed Practical Nurses (LPNs) to improve both blood pressure control and depressive symptoms, unlike traditional treatments that often address these conditions separately.1381112
Research Team
Jennifer Levin, PhD
Principal Investigator
University Hospitals Cleveland Medical Center
Eligibility Criteria
This trial is for young African-American women under 50 with depression and at risk for high blood pressure, but not yet diagnosed with it. Participants must have a BMI ≥30, HbA1c >5.75, a recent BP reading of ≥130/90 mmHg, be current smokers or have LDL levels ≥100 mg/dl.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the TEAM-Red intervention or are placed on an enhanced waitlist control for 24 weeks
Follow-up
Participants are monitored for changes in depression and stress levels using PHQ-9 and PSS-10 scores
Treatment Details
Interventions
- TEAM-Red
- Waitlist
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jennifer B. Levin
Lead Sponsor
American Heart Association
Collaborator